A detailed history of Baader Bank Aktiengesellschaft transactions in In Med Pharmaceuticals Inc. stock. As of the latest transaction made, Baader Bank Aktiengesellschaft holds 22,611 shares of INM stock, worth $5,426. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,611
Holding current value
$5,426
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$0.12 - $0.43 $2,713 - $9,722
22,611 New
22,611 $5,000

Others Institutions Holding INM

About InMed Pharmaceuticals Inc.


  • Ticker INM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 908,761
  • Market Cap $218K
  • Description
  • InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...
More about INM
Track This Portfolio

Track Baader Bank Aktiengesellschaft Portfolio

Follow Baader Bank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baader Bank Aktiengesellschaft, based on Form 13F filings with the SEC.

News

Stay updated on Baader Bank Aktiengesellschaft with notifications on news.